Results

Total Results: 2,582 records

Showing results for "testing".

101. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/immunity-after-covid/rapid-review
     April 01, 2023 - What are the unintended consequences of antibody testing after SARS-CoV-2 infection? … Most studies did not perform protocolized follow-up testing designed to capture all incident infections … Antibody testing has been proposed as a potential marker or correlate of protection against infection … In these situations, the prognostic value of antibody testing was identical to the prognostic value of … settings when the timing of testing in relation to infection is unknown.

102. Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA): Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/mrsa-screening/research
     December 01, 2019 - The screening strategy may use a testing modality with a rapid turnaround time (results available on … the same day as the testing is performed, typically using polymerase chain reaction (PCR), intermediate … turnaround time (results available next day to 2 days after testing performed) or longer turnaround … time (results available greater than 2 days after testing performed, typically culture).

103. PROPOSALS FOR A PHASED EVALUATION OF (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/whitepaper3-lijmer02262010-2.pdf
     January 01, 2009 - Premature dissemination of testing technologies can lead to erroneous diagnoses and preventable delays … The ultimate question in decisions about testing is how much net gain from testing there will be for … The benefits from testing may be limited to a subset of those tested, so sample size requirements can … be substantial.45 Trials of testing need a well-defined protocol that links testing, results, and downstream … All of these practical problems are challenging but not insurmountable, and trials of testing can be

104. PROPOSALS FOR A PHASED EVALUATION OF (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medical-tests-proposals_research.pdf
     January 01, 2009 - Premature dissemination of testing technologies can lead to erroneous diagnoses and preventable delays … The ultimate question in decisions about testing is how much net gain from testing there will be for … The benefits from testing may be limited to a subset of those tested, so sample size requirements can … be substantial.45 Trials of testing need a well-defined protocol that links testing, results, and downstream … All of these practical problems are challenging but not insurmountable, and trials of testing can be

105. Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/musculoskeletal-complaints-tests-children/research-protocol
     December 01, 2019 - Reports Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing … Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing … No systematic reviews examining ANA for pediatric SLE or RF and CCP testing for JIA were identified. … Antinuclear antibody (ANA) testing. Pediatr Rev 2003;24:320-1. Syed RH, Gilliam BE, Moore TL. … Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis.

106. Diagnosis of Celiac Disease: Current State of the Evidence (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/celiac-disease_clinician.pdf
     July 01, 2016 - Testing for the presence of HLA-DQ2 or HLA-DQ8 has excellent sensitivity and negative predictive value … For children younger than 2 years, the ACG guidelines recommend initial testing with tTG IgA, DGP IgA … a Sensitivity and specificity values are for point-of-care testing. b Sensitivity and specificity values … a Sensitivity and specificity values are for point-of-care testing. b Sensitivity and specificity values … Testing algorithms �� All algorithms studied used tTG tests.

107. Fractional Exhaled Nitric Oxide Clinical Utility in Asthma Management | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/asthma-nitric-oxide/research-protocol
     June 01, 2021 - the diagnosis of asthma is challenging, given their inability to participate in the usual diagnostic testing … In children ages 0-4 years with recurrent wheezing, how accurate is FeNO testing in predicting the future … Comparators KQ 1a: Standard diagnostic testing of asthma made by healthcare providers based on history … Use of bronchodilators prior to FeNO testing Whether appropriate testing protocol was followed ( … We will iteratively continue testing the form until no additional items or unresolved questions exist

108. Making Healthcare Safer IV: Active Infection Surveillance of Clostridioides difficile and Multi-Drug Resistant Organisms: Methicillin-Resistant Staphylococcus aureus (MRSA), Carbapenem-Resistant Enterobacterales (CRE), Candida auris | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/mhs4-active-infection/protocol
     September 01, 2023 - Additionally, owing to the overlapping findings of the C.difficile testing chapter in MHS III, our … surveillance, along with screening and testing in asymptomatic patients. … in 2017, there has been an acceleration in publications evaluating C.difficile testing and diagnostic … outside of outbreak surveillance testing Multicomponent interventions in which the isolated effect of … surveillance cannot be evaluated Testing stewardship interventions No microbial organism of interest

109. Hi Les, (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rtc-design-principles_research.pdf
     January 01, 2009 - Critical steps in the pathway between testing and patient outcomes, such as differences in test accuracy … These RCTs should have long-term followup to capture all immediate and downstream consequences of testing … It may involve no prior testing if the new test is intended for primary screening or for monitoring … Other pathways It is possible that the availability of D-dimer lowers the threshold for testing in … Additional patient outcomes and pathways in evaluations of testing.

110. Comparative Effectiveness of Noninvasive Technologies for the Diagnosis of Coronary Artery Disease (CAD) in Women | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cad-women-diagnosis/research-protocol
     December 01, 2019 - with exercise ECG is the oldest and most commonly used form of stress testing. … . 3 In summary, many factors affect the accuracy of diagnostic testing for CAD in women, 3 including … . 4 After undergoing coronary angiography, some patients may be referred for noninvasive stress testing … Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease … ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College

111. Brooks_ECCS2012 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/brooks_eccs2012.pdf
     January 01, 2012 - Slide 13: Patient Decision Aid Image of Testing for Prostate Cancer: “Should  I be tested? … men. • There are  tests  to  find it early. • We don’t  yet  know  if the benefits of testing …  outweigh the risks. • Men  should learn  about  prostate cancer and testing,  then  decide … if testing  is the right  choice for them.

112. Work Plan for Methods Research on (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/study-design-classification_research.pdf
     December 01, 2010 - from the 30 studies used for the first round of testing. … The same analyses were conducted for the second round of testing. … Pilot testing the tool in the context of each review is highly recommended. … The same analyses were conducted for the second round of testing. … We made minor revisions following the final round of testing that merit further testing.

113. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
     September 08, 2011 - Direct evidence of the impact of testing on health outcomes is shown by link A (morbidity, function … , quality of life and/or mortality) and link G (adverse events of testing). … An early link in an indirect chain of evidence concerns the diagnostic accuracy of testing (B). … HER2 Testing to Manage Patients With Breast Cancer or Other Solid Tumors. … The harms of the testing procedure itself would relate to venipuncture. II.

114. Proposals for a Phased Evaluation of Medical Tests | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/medical-tests-proposals/research
     December 01, 1969 - Premature dissemination of testing technologies can lead to erroneous diagnoses and preventable delays … The ultimate question in decisions about testing is how much net gain from testing there will be for … The benefits from testing may be limited to a subset of those tested, so sample size requirements can … be substantial. 45 Trials of testing need a well-defined protocol that links testing, results, and … It is inevitable that such trials evaluate the effectiveness of testing as well as that of downstream

115. Test-Performance-Metrics Appendixes (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/test-performance-metrics_appendixes.pdf
     January 01, 2005 - Sensitivity and Specificity Sensitivity, also known as the true positive rate, is the probability of testing … Specificity, or true negative rate, is the probability of testing negative for non-diseased patients

116. Evidence-based Practice Center Systematic Review Protocol - Management of Infantile Epilepsies (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-disposition-comments.pdf
     October 25, 2022 - Since the report did not contain a Key Question or Contextual Question about genetic testing, it would … We did look through our database and identified some studies of genetic testing and genome sequencing … We did look through our database and identified some studies of genetic testing and genome sequencing … We did look through our database and identified some studies of genetic testing and genome sequencing … Thank you for this comment, AHRQ may consider genetic testing for future reports.

117. Data Points #20: Echocardiography Trends | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/echocardiography/research
     December 01, 2019 - The criteria vary by previous service and clinical indication, but in general echocardiography testing … The presence of testing equipment for echocardiography in primary care offices has been hypothesized … still unclear - in the case of stress echocardiography, the relationship between the office location of testing … material and increased cost of care after testing is modest.

118. The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/asthma-nitric-oxide/research
     October 01, 2019 - Using FeNO cutoffs of <20, 20-30, 30-40, =40 part per billion (ppb); respectively, FeNO testing had sensitivities … FeNO testing may identify patients who were more likely to respond to inhaled corticosteroids (SOE: Low … FeNO testing predicted exacerbations in patients undergoing ICS reduction or withdrawal. … The Diagnostic Accuracy of Fractional Exhaled Nitric Oxide Testing in Asthma: A Systematic Review and

119. Immunity After COVID-19 | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/immunity-after-covid/protocol
     June 01, 2021 - Although testing for antibodies to SARS-CoV-2 is becoming more common, how these tests should be utilized … What are the unintended consequences of antibody testing after SARS-CoV-2 infection? Table 1. … KQ 2-3: Adults with viral RT-PCR confirmed SARS-CoV-2 infection who underwent serologic testing using … We revised our definition of reinfection to be more representative of testing capabilities in real-world … Early in the pandemic, PCR testing was strictly done on symptomatic patients to conserve resources in

120. Prostate-Cancer-Test Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
     April 01, 2013 - 1 Comparative Effectiveness Review Number 98 PCA3 Testing for the Diagnosis and Management of Prostate … subjects/populations (at-risk men or men with a positive biopsy); (3) study interventions (biomarker testing … KQ 3: Testing PCA3 and Comparators To Identify Men With Insignificant Cancer Who May Benefit From Active … Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical … PCA3 Testing for the Diagnosis and Management of Prostate Cancer.